Adverts

Open Access Articles- Top Results for CJ-033466

CJ-033466

</th></tr>
CJ-033466
220px
Systematic (IUPAC) name
5-amino-6-chloro-2-methyl-N-([1-(2-methylpropyl)piperidin-4-yl]methyl)imidazo[1,2-a]pyridine-8-carboxamide
Clinical data
Identifiers
PubChem CID 10429706
Chemical data
Formula C19H28ClN5O
377.910 g/mol
 14pxY (what is this?)  (verify)

CJ-033466 is a drug which acts as a potent and selective 5-HT4 serotonin receptor partial agonist. In animal tests it stimulated gastrointestinal motility with 30 times the potency of cisapride, and with lower affinity for the hERG channel.[1][2][3]

References

  1. ^ Mikami T, Ochi Y, Suzuki K, Saito T, Sugie Y, Sakakibara M (April 2008). "5-Amino-6-chloro-N-[(1-isobutylpiperidin-4-yl)methyl]-2-methylimidazo[1,2-alpha]pyridine-8-carboxamide (CJ-033,466), a novel and selective 5-hydroxytryptamine4 receptor partial agonist: pharmacological profile in vitro and gastroprokinetic effect in conscious dogs". The Journal of Pharmacology and Experimental Therapeutics 325 (1): 190–9. PMID 18198343. doi:10.1124/jpet.107.133850. 
  2. ^ Toga T, Kohmura Y, Kawatsu R (October 2007). "The 5-HT(4) agonists cisapride, mosapride, and CJ-033466, a Novel potent compound, exhibit different human ether-a-go-go-related gene (hERG)-blocking activities". Journal of Pharmacological Sciences 105 (2): 207–10. PMID 17928736. doi:10.1254/jphs.sc0070243. 
  3. ^ Tsuchida Y, Hatao F, Fujisawa M, Murata T, Kaminishi M, Seto Y, Hori M, Ozaki H (May 2011). "Neuronal stimulation with 5-hydroxytryptamine 4 receptor induces anti-inflammatory actions via α7nACh receptors on muscularis macrophages associated with postoperative ileus". Gut 60 (5): 638–47. PMC 3071096. PMID 21115544. doi:10.1136/gut.2010.227546. 



Lua error in package.lua at line 80: module 'Module:Buffer' not found.